文献速递重症综合管理与镇静镇痛心脑血管急症

危重症后持续性认知障碍的危险因素:巢式病例对照研究

Risk Factors for Persistent Cognitive Impairment After Critical Illness, Nested Case-Control Study.
PubMed 文献 · Crit Care Med · 2018-01-01
一句话结论ICU住院期间急性脑功能衰竭、严重低血压、低氧血症、高热、血糖波动及喹诺酮类或万古霉素暴露与新发持续性认知障碍相关。

该研究为观察性病例对照研究,嵌套于2004年7月1日至2015年11月20日Mayo Clinic ICU收治的98,227例成人危重症患者队列。主要终点为ICU出院后3至24个月记录的新发持续性认知障碍。21,923例(22%)被识别为认知受损,其中2,428例(2.5%)在指数ICU入院后出现新发持续性认知功能障碍。与年龄和性别匹配的ICU对照(2,401对)相比,病例组慢性疾病负担更高(Charlson合并症指数6.2 vs 5.1;p<0.01),多次ICU住院更常见(22% vs 14%;p<0.01)。校正基线差异后,新发持续性认知功能障碍与ICU内急性脑功能衰竭频率更高、严重低血压、低氧血症、高热、血清葡萄糖波动以及喹诺酮类或万古霉素治疗相关。单因素分析中与脓毒症的关联在校正后未持续存在。

要点

  • 在98,227例成人ICU队列中,2,428例(2.5%)发生新发持续性认知障碍,定义为ICU出院后3至24个月记录的新发持续性认知障碍。
  • 与年龄和性别匹配的ICU对照(2,401对)相比,病例组Charlson合并症指数更高(6.2 vs 5.1;p<0.01),多次ICU住院比例更高(22% vs 14%;p<0.01)。
  • 校正基线差异后,新发持续性认知障碍与ICU内急性脑功能衰竭频率更高、严重低血压、低氧血症、高热、血清葡萄糖波动以及喹诺酮类或万古霉素治疗相关。
  • 单因素分析中与脓毒症的关联在校正后未持续存在。
  • 慢性合并症和ICU住院次数增加危重症后认知功能障碍风险,且不依赖于年龄;可改变的ICU暴露被确定为未来预防试验的潜在靶点。

适用人群与场景

  • Mayo Clinic ICU于2004年7月1日至2015年11月20日收治的成人危重症患者,嵌套于98,227例大型队列。
  • 病例组为指数ICU入院后出现新发持续性认知功能障碍者,对照为年龄和性别匹配的ICU患者(2,401对)。

诊断标准与关键阈值

  • 使用先前验证的可计算表型确定痴呆和认知障碍,并判定认知障碍相对于ICU住院的发生时间。
  • 主要终点为新发持续性认知障碍,定义为ICU出院后3至24个月记录的新发持续性认知障碍。

研究设计与关键结果

  • 研究类型为观察性病例对照研究,嵌套于98,227例成人危重症患者队列,数据来自Mayo Clinic ICU,时间为2004年7月1日至2015年11月20日。
  • 21,923例(22%)被识别为认知受损,其中2,428例(2.5%)在指数ICU入院后出现新发持续性认知功能障碍。
  • 与年龄和性别匹配的ICU对照(2,401对)相比,病例组Charlson合并症指数更高(6.2 vs 5.1;p<0.01),多次ICU住院更常见(22% vs 14%;p<0.01)。
  • 校正基线差异后,新发持续性认知功能障碍与ICU内急性脑功能衰竭频率更高、严重低血压、低氧血症、高热、血清葡萄糖波动以及喹诺酮类或万古霉素治疗相关。
  • 单因素分析中与脓毒症的关联在校正后未持续存在。

证据类型、等级与局限

  • 证据类型:观察性病例对照研究(巢式于大型队列)。

对床旁实践的改变

  • 慢性合并症和ICU住院次数增加危重症后认知功能障碍风险,且不依赖于年龄。
  • 可改变的ICU暴露(急性脑功能衰竭、严重低血压、低氧血症、高热、血清葡萄糖波动、喹诺酮类或万古霉素治疗)被确定为未来预防试验的潜在靶点。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Persistent cognitive impairment after critical illness is an important healthcare problem forecasted to worsen in the near future. However, the epidemiology is insufficiently explored. We aimed to determine potentially modifiable risk factors during ICU hospitalization that play a significant role in developing persistent cognitive impairment.

DESIGN: An observational case-control study.

SETTINGS: Mayo Clinic ICUs between July 1, 2004, and November 20, 2015.

PATIENTS: We conducted a study nested in a large cohort of 98,227 adult critically ill patients. Using previously validated computable phenotypes for dementia and cognitive impairment, we determined the onset of cognitive impairment relative to ICU hospitalization and associated risk factors. The primary endpoint of the study was new and persistent cognitive impairment documented between 3 and 24 months after ICU discharge.

INTERVENTIONS: Unadjusted and adjusted analyses were performed to identify potentially modifiable risk factors during ICU hospitalization.

MEASUREMENTS AND MAIN RESULTS: Among 21,923 unique patients identified as cognitively impaired (22% of the entire ICU cohort), 2,428 (2.5%) developed incident new and persistent cognitive dysfunction after the index ICU admission. Compared with age- and sex-matched ICU controls (2,401 pairs), cases had higher chronic illness burden (Charlson Comorbidity Index, 6.2 vs 5.1; p < 0.01), and were more likely to have multiple ICU stays (22% vs 14%; p < 0.01). After adjustment for baseline differences, new and persistent cognitive dysfunction was associated with higher frequency of acute brain failure in the ICU, a higher exposure to severe hypotension, hypoxemia, hyperthermia, fluctuations in serum glucose, and treatment with quinolones or vancomycin. Association with sepsis observed in univariate analysis did not persist after adjustment.

CONCLUSIONS: Cognitive dysfunction is highly prevalent in ICU patients. Incident new and persistent cognitive impairment is less common but important, potentially preventable problem after critical illness. Chronic comorbidities and number of ICU stays increase the risk of post-ICU cognitive dysfunction irrespective of age. Modifiable ICU exposures were identified as potential targets for future prevention trials.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Sakusic A, Gajic O, Singh TD, et al. Risk Factors for Persistent Cognitive Impairment After Critical Illness, Nested Case-Control Study. Crit Care Med. 2018. PMID: 30222636. doi:10.1097/CCM.0000000000003395

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。